IP Library Granted Patent US 10,370,457
Granted Patent B2
US 10,370,457 · App. 15/410,425 · Granted Aug 6, 2019

Antibodies to paliperidone haptens and use thereof

Inventors: Eric Hryhorenko (Hilton, NY); Banumathi Sankaran (Lexington, MA); Thomas R. DeCory (Pittsford, NY); Theresa Tubbs (Rochester, NY); Linda Colt (Rochester, NY); Maarten Vliegen (Rijkevorsel, BE); Pieter Rik Haspeslagh (Halen, BE)
Assignee: Janssen Pharmaceutica NV
C07K16/44G01N33/94G01N33/9406C07K2317/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,370,457
App. No.
15/410,425
Granted
Aug 6, 2019
Kind
B2
Abstract

Disclosed is an antibody which binds to paliperidone, which can be used to detect paliperidone in a sample such as in a competitive immunoassay method. The antibody can be used in a lateral flow assay device for point-of-care detection of paliperidone, including multiplex detection of aripiprazole, olanzapine, quetiapine, risperidone and paliperidone in a single lateral flow assay device.

Claims (28)

1. A method of producing an antibody or a binding fragment thereof which binds to paliperidone, the method comprising:

(i) selecting a host for antibody production; and

(ii) inoculating the host with a conjugate of a compound of Formula I and an immunogenic carrier, wherein the host produces an antibody which binds to paliperidone,

wherein

L 1 is OC(O)(CH 2 ) n , or O(CH 2 ) n ;

wherein n is 2 or 3;

L 2 is NHC(O),

or absent;

L 3 is (CH 2 ) m CO 2 H, or

wherein m is 0, 1, 2, or 3; provided that m may only be 0 if L 2 is absent, and further provided that when L 2 is absent L 3 is

2. A method of producing a hybridoma cell line capable of producing a monoclonal antibody which binds to paliperidone, the method comprising:

(i) selecting a host for antibody production;

(ii) inoculating the host with a conjugate of a compound of Formula I and an immunogenic carrier;

(iii) fusing a cell line from said inoculated host with a continuously dividing cell to create a fused cell capable of producing a monoclonal antibody which binds to paliperidone; and

(iv) cloning the fused cell so as to obtain a hybridoma cell line,

wherein

L 1 is OC(O)(CH 2 ) n , or O(CH 2 ) n ;

wherein n is 2 or 3;

L 2 is NHC(O),

or absent;

L 3 is (CH 2 ) m CO 2 H, or

wherein m is 0, 1, 2, 3; provided that m may only be 0 if L 2 is absent, and further provided that when L 2 is absent L 3 is

3. The method of claim 1 , wherein the immunogenic carrier is a protein.

4. The method of claim 3 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

5. The method of claim 2 , wherein the immunogenic carrier is a protein.

6. The method of claim 5 , wherein the protein is keyhole limpet hemocyanin, bovine thyroglobulin, or ovalbumin.

7. The method of claim 1 , wherein the antibody binding fragment is selected from the group of fragments consisting of Fv, F(ab′), F(ab′)2, scFv, minibody and diabody fragments.

8. The method of claim 1 , wherein the antibody is a monoclonal antibody.

Continuity (3)
Division 13971387 · Aug 20, 2013
Provisional Application 61691634 · Aug 21, 2012
Related Publication 20170129968A1 · May 11, 2017